Abstract
We performed an observational cohort study in order to assess the correlation between precancerous cervical lesions (cervical intraepithelial neoplasia [CIN]) and immunological state in human immunodeficiency virus (HIV)-positive women treated by highly active antiretroviral therapy (HAART). We analyzed 194 HIV-infected women referred to the Parma-Universitary Hospital for early detection of human papilloma virus–induced CINs. We analyzed cytology, colposcopy, and CIN degree according to HAART: group A untreated and group B treated. We compared the CD4+ count and viral load at the time of CIN onset and the time interval between diagnosis of HIV and the onset of CIN. Group A and group B showed homogeneous results for general features, CD4+ count, viral load, and Papanicolaou test features. Differences were not found in terms of histology and CD4+ value, viral load count, pharmacological treatment, years since the diagnosis of HIV, age, smoking, sexual promiscuity, previous intravenous narcotics abuse, prostitution, sexually transmitted diseases, ethnicity, and age at diagnosis. Histology and the clinical stage of HIV showed significant concordances between the high degree of cervical dysplasia and advanced stage of HIV disease.
Similar content being viewed by others
References
IARC: Monographs on the Evalutation of carcinogenic risks to Humans Volume 90. Human Papillomaviruses Lyon: AIRC Press; 2007. http://monographs.iarc.fr/ENG/Monographs/vol90/mono90.pdf. Accessed May 2013.
Dal Maso L, Franceschi S, Lise M, et al. Screening of HIV-positive women in Emilia-Romagna (SHER) Study. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010;10:310.
Dal Maso L, Polesel J, Serraino D, et al. Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009; 100(5):840–847.
Anastos K, Hoover DR, Burk RD, et al. Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women. PLoS One. 2010;5(10):el3525.
Gizzo S, Ancona E, Patrelli TS, et al. Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery? Cancer Invest. 2013;31(3):189.
Clifford GM, Franceschi S. Cancer risk in HIV-infected persons: influence of CD4(+) count. Future Oncol. 2009;5(5):669–678.
Mogtomo ML, Malieugoue LC, Djiepgang C, Wankam M, Moune A, Ngane AN. Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer. 2009;4:9.
Gonçalves MA, Soares EG, Donadi EA. The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect Agent Cancer. 2009;4:11.
Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; La colposcopia in Italia XII; 1, 2006. http://sigo.web-designer-roma.com/usr_files/linee-guida-sigo/LineeGuidaColposcopia06.pdf. Accessed May 2013.
Società Italiana di Colposcopia e Patologia Cervico-Vaginale. Linee guida nella Gestione della Paziente con Pap Test Anormale; 1, 2002.
The 1988 Bethesda system for reporting cervical/vaginal cytolo-gical diagnoses. national cancer institute workshop. JAMA. 1989;262(7):931–934.
Broder S. From the national institutes of health. JAMA. 1992; 267(14):1892.
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114–2119.
Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031–1037.
De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev. 2008;17(6):545–554.
Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol. 2003;15(5):382–388.
Stern PL, Brown M, Stacey SN, et al. Natural HPV immunity and vaccination strategies. J Clin Virol. 2000;19(1–2):57–66.
Gage JR, Sandhu AK, Nihira M, et al. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol. 2000;96(6):879–885.
Massad LS, Evans CT, Weber KM, et al. Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus. Obstet Gynecol. 2010;116(4):941–947.
Saccardi C, Gizzo S, Noventa M, et al. High-risk human papillomavirus DNA test: could it be useful in low-grade cervical lesion triage? five-year follow-up [published online June 6, 2013]. Reprod Sci. 2013.
Soncini E, Zoncada A, Condemi V, Antoni AD, Bocchialini E, Soregotti P. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Biomed. 2007;78(1):36–40.
Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;51(3):274–282.
Sirera G, Videla S, López-Blázquez R, et al. Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3. JAntimicrob Chemother. 2008;61(1):191–194.
Heard I. Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS. 2009;4(1):68–73.
Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol. 2009;113(1):26–31.
Massad LS, Evans CT, Wilson TE, et al. Knowledge of cervical cancer prevention and human papillomavirus among women with HIV. Gynecol Oncol. 2010;117(1):70–76.
Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA, HIV/AIDS Cancer Match Study. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007; 99(12):962–972.
Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425–432.
Tsai HT, Tsai YM, Yang SF, et al. Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm-a community-based case-control study. Gynecol Oncol. 2007; 105(1):181–188.
Minkoff H, Zhong Y, Burk RD, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010;201(5):681–690.
Gizzo S, Noventa M, Nardelli GB. Gardasil administration to hr-HPV-positive women and their partners. Trends Pharmacol Sci. 2013;34(9):479–480.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Patrelli, T.S., Gizzo, S., Peri, F. et al. Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study. Reprod. Sci. 21, 837–845 (2014). https://doi.org/10.1177/1933719113512531
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719113512531